Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages (Q45711444)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2002

Language	Label	Description	Also known as
English	Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages	scientific article published in February 2002

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages (English)

1 reference

Europe PubMed Central

15 December 2017

Giulia Chinetti

2

1 reference

Europe PubMed Central

15 December 2017

10

1 reference

Europe PubMed Central

15 December 2017

Fruchart-Najib J

9

object named as

Fruchart-Najib J

1 reference

Europe PubMed Central

15 December 2017

author name string

Gbaguidi FG

1

1 reference

Europe PubMed Central

15 December 2017

Milosavljevic D

3

1 reference

Europe PubMed Central

15 December 2017

Teissier E

4

1 reference

Europe PubMed Central

15 December 2017

Chapman J

5

1 reference

Europe PubMed Central

15 December 2017

Olivecrona G

6

1 reference

Europe PubMed Central

15 December 2017

Fruchart JC

7

1 reference

Europe PubMed Central

15 December 2017

Griglio S

8

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

512

1 reference

Europe PubMed Central

15 December 2017

1-3

1 reference

Europe PubMed Central

15 December 2017

85-90

1 reference

Europe PubMed Central

15 December 2017

Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Lipoprotein lipase can function as a monocyte adhesion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Expression and regulation of the lipoprotein lipase gene in human adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Effects of ethanol intake on lipoprotein lipase activity in adipose tissue of fasting subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Automated Peptide Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

21 January 2018

Oxidized LDL binding to a macrophage-secreted extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Glycated low-density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902223-8

7 January 2021

Identifiers

10.1016/S0014-5793(02)02223-8

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45711444&oldid=2077677206"